Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MGTX

+ Watchlist+ Portfolio

MeiraGTx Holdings plc

Regulated industryDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$8.46
52-Week Range
$6.62 – $15.35
Market Cap
$813.12M
P/E (TTM)
9.56
EPS (TTM)
0.87
Dividend Yield
0.00%
Advanced Metrics
Price/Book
3.78
PEG Ratio
—
Return on Equity
89.50%
Return on Assets
37.47%
Gross Margin
97.20%
Operating Margin
44.84%
Profit Margin
19.48%
Current Ratio
4.63
Debt/Equity
0.62
Total Debt
$133.85M
Free Cash Flow
$47.40M
Revenue Growth
1074.10%
Earnings Growth
—
Enterprise Value
$762.46M

Market Snapshot

About

MeiraGTx Holdings is a clinical-stage gene therapy company developing treatments for inherited retinal diseases, neurodegenerative disorders, and xerostomia. The company uses AAV and lentiviral vector technologies to deliver genetic therapies.